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Abstract
Background: M.tuberculosis (M.tb) is associated with enhanced T helper cell type 1 (Th1) immune responses while
helminth infection is associated with T helper cell type 2 (Th2) immune responses. Our aim was to investigate
whether helminth infection could influence the ability to generate an appropriate Th1 immune response that is
characterized by a positive tuberculin skin test (TST), in M.tb exposed children.
Methods: We completed a community-based, cross sectional household contact tracing study, using matched
enrolment of HIV negative children with and without documented household M.tb exposure. We documented
demographics, clinical characteristics, HIV status, M.tb exposure (using a standard contact score) and M.tb infection
status (TST > = 10 mm). Ascaris lumbricoides-specific IgE was used as proxy for Ascaris infection/exposure.
Results: Of 271 children (median age 4 years (range: 4 months to 15 years)) enrolled, 65 participants (24%) were
serum positive for Ascaris IgE. There were 168 (62%) children with a documented household tuberculosis contact
and 107 (40%) were (TST) positive overall.
A positive TST was associated with increasing age (Odds Ratio (OR) =1.17, p < 0.001), increasing M.tb contact score
(OR = 1.17, p < 0.001), previous tuberculosis treatment (OR = 4.8, p = 0.06) and previous isoniazid preventive
treatment (OR = 3.16, p = 0.01). A visible bacillus Calmette-Guérin (BCG) scar was associated with reduced odds of
being TST positive (OR = 0.42, p = 0.01).
Ascaris IgE was not associated with TST status in univariate analysis (OR = 0.9, p = 0.6), but multivariable logistic
regression analysis suggested an inverse association between Ascaris IgE status and a positive TST (OR = 0.6,
p = 0.08), when adjusted for age, and M.tb contact score. The addition of an age interaction term to the model
suggested that the age effect was stronger among Ascaris IgE positive children; the effect of being Ascaris IgE
positive significantly reduced the odds of being TST positive amongst younger children while this effect weakened
with increasing age.
Conclusions: Our preliminary findings highlight a high prevalence of both Ascaris exposure/infection and M.tb
infection in children in an urban setting. Helminth exposure/infection may reduce the immune response following
M.tb exposure when controlling for epidemiological and clinical covariates. These findings might be relevant to the
interpretation of immunological tests of M.tb infection in children.
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Background
Infectious diseases are important causes of morbidity
and mortality in children living in the developing world.
Tuberculosis is a major global threat with an estimated
9.4 million incident cases reported globally in 2009 [1],
with South Africa ranked third with an estimated annual
notification rate of 971 per 100 000 per year [1]. Paediat-
ric tuberculosis contributes an estimated 15-20% of the
overall global caseload, with >80% cases notified from
the 22 so-called “high-burden” countries, including
South Africa [2]. Young children exposed to and
infected with Mycobacterium tuberculosis (M.tb) are at
high risk for disease progression in the absence of effect-
ive chemoprophylaxis [3].
Poor socio-economic circumstances, prevalent in
many settings with a high burden of tuberculosis, also
predispose to poor living conditions, overcrowding and
increased risk of helminth exposure and infection [4,5].
Helminth infection in children is often chronic and is
associated with anaemia, growth retardation, impaired
cognitive functioning and chronic inflammatory diseases
[6-8]. The World Health Organization (WHO) classifies
South Africa as one of the 130 helminth-endemic coun-
tries (prevalence of infection > 20% - 50%) [9]. The
WHO Integrated Management of Childhood Illness
(IMCI) guidelines therefore routinely recommend regu-
lar deworming in children older than 1 year [10]; how-
ever, this is not consistently practiced and the constant
risk of re-infection remains high in helminth-prevalent
settings [4,5].
M.tb exposure involves complex immune processes
and leads to a spectrum of infection and clinical disease
outcomes in children, including M.tb-exposed but unin-
fected, infected non-diseased and diseased [11,12]. In
addition to innate host immunity, protection against M.
tb requires an effective adaptive cellular immune re-
sponse characterized by robust T helper cell type 1 (Th1)
T-cell immunity and relative weaker T helper cell type 2
(Th2) T-cell immune responses [13-17]. The tuberculin
skin test (TST), the most established clinical-
epidemiological immune measure of M.tb infection, is a
marker of a Th1-type delayed type hypersensitivity reac-
tion. Previously M.tb-sensitized circulating lymphocytes
are attracted to the intra-dermal tuberculin injection site,
followed by monocyte, macrophage, CD4+− and CD8+
T-lymphocyte accumulation and release of inflammatory
mediators that causes clinical erythema and oedema [12].
Th2 cells produce cytokines which play a role in pro-
tection against extracellular organisms and are increased
in the presence of helminth infection [18-21], specifically
Ascaris lumbricoides [20] and hookworm species [20,21].
Data regarding the role of Th2 cells in the presence of
Trichiuris trichiura infection are inconsistent [15,22].
Th2 cell types impair signal transduction and induce
anergy of immune cells, which might decrease the ability
to generate protective cellular immunity to protect
against common infections, like M.tb and to routine vac-
cinations [19]. Helminth infection is further associated
with suppressive T-cell population induction and inhibi-
tory cytokine production which can suppress Th1-type
responses and interfere with effector T-cell activation,
potentially resulting in altered memory immune
responses against M.tb [15].
The current limited evidence supports a potential im-
mune modulating effect of helminths on mycobacterial
immune responses in humans [15,21,23], although
contradictory evidence also exists [24,25]. We therefore
investigated the effect of an Ascaris-specific IgE positive
status on a commonly used marker of M.tb infection
(TST), in children in a setting with a high burden of tu-
berculosis. We hypothesized primarily that helminth in-
fection in children, while controlling for M.tb exposure
and other relevant covariates, would decrease the ability
to generate an appropriate Th1 immune response char-
acterized by a positive TST in children.
Methods
This was a prospective cross-sectional community-based
study. Study participants were recruited from three high
burden tuberculosis communities: Ravensmead, Uitsig
(R/U) and Site C, Khayelitsha (Site C), in Cape Town,
Western Cape Province, South Africa. The communities
are demographically heterogeneous, and respectively rep-
resent ethnic groups that are predominantly of South Af-
rican Mixed (R/U) and Xhosa African ancestry (Site C).
The tuberculosis notification rate in the province was
994 per 100 000 in adults and 671 per 100 000 in children
aged 0 – 14 years in 2008 (Western Cape Department of
Health, unpublished data). There is near universal infant
bacille Calmette-Guérin (BCG) vaccination.
Prior surveys from school-going children in R/U found
that 25% were stool positive for Ascaris lumbricoides
and 51% for Trichuris trichiura[26]. Routine clinic and
school-based deworming has since become standard of
care in local health care centres. There are currently no
published data on the prevalence of helminth infection
in children in Khayelitsha.
Participants were recruited following identification of
consenting adults (≥ 18 years of age), who routinely
started tuberculosis treatment in the preceding 3 months
(“source case”) at the local clinic. Participants were eli-
gible for enrolment if they were a household child con-
tact between 3 months and 15 years of age. Households
were identified through TB source cases (“tuberculosis
households”), and matched neighbouring households
without known tuberculosis exposure (“neighbouring
households”). The ratio between tuberculosis and neigh-
bouring households was approximately 1:1.
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We identified tuberculosis households within 2–
4 weeks following the adult source case identification,
then completed a home visit and collected data on M.tb
exposure and demographic characteristics. In addition,
all adult household members were screened for symp-
toms of tuberculosis followed by sputum collection, if
they were symptomatic.
Following written informed consent from the parents/
caregivers, children aged 3 months – 15 years who were
not currently on tuberculosis therapy, were enrolled in
the study. Children were deferred for enrolment if there
was a) prior TST administration in the preceding
3 months, b) live measles or polio vaccine within the
past 6 weeks or c) recent acute illness requiring
hospitalization (preceding 6 weeks). Children on isonia-
zid preventive therapy (IPT) were not excluded, whereas
HIV-infected children were.
All children were investigated for M.tb infection and
disease using standard protocols [27,28], including
TST, a standard symptom questionnaire , blinded inde-
pendent dual expert review of chest radiographs (pos-
tero-anterior and lateral), sputum or gastric washing
for mycobacterial culture (Mycobacterial Growth Indi-
cator Tubes; Becton Dickinson, Sparks, USA), a TST,
and clinical examination.
The TST (Mantoux method; 2 tuberculin units puri-
fied protein derivative; Statens Serum Institute, Copen-
hagen) was administered intra-dermally on the volar
aspect of the left forearm by trained standardized study
nurses, and read within 48–72 hours using the ball-
point and ruler method and callipers. The TST was
regarded as positive if measuring ≥10 mm in HIV-
negative children for clinical care. Unless already known
to be HIV-infected, participants were tested for HIV
(Abbott Determine Rapid HIV test), followed by a con-
firmatory laboratory based ELISA/PCR test if positive or
indeterminate.
Data were collected to quantify the degree of M.tb ex-
posure (M.tb contact score) [29]. In the absence of a
gold standard of infection, we used this score to quantify
the degree of exposure in children as a surrogate refer-
ence standard for M.tb infection [29-31] [Table 1]. The
score includes measures of source case infectivity, the
average reported duration of exposure to the source
case, and the child’s reported proximity to the source
case. TST results in children from the study communi-
ties were previously shown to be well correlated with
this score [29,30].
We also recorded information on BCG vaccination
history and scar presence, previous and current isoniazid
preventive therapy, previous tuberculosis treatment, nu-
tritional status (z-scores), household composition, mea-
sures of socio-economic status (household assets), and
reported history of deworming during the preceding
6 months. Z-scores were calculated with reference to the
2006 World Health Organization Child Growth Stan-
dards for children up to five years of age and the 2000
Centres for Disease Control and Prevention growth
charts reference population for children that were older
than 5 years [32]. Reported socio-economic indicators
were based on surveys in our study communities and
were used in the absence of reliable data on reported in-
come, given high unemployment rates in these impover-
ished urban communities.
Sensitization to Ascaris lumbricoides was determined
by the ImmunoCAP specific-IgE testing which measures
circulating Ascaris-specific IgE concentration in serum.
This method was developed for clinical diagnosis and la-
boratory use where reagins belonging to the IgE anti-
body class, which develop shortly after exposure, are
measured by a fluoroenzymeimmunoassay [33]. Results
are expressed as kU/L and are typically categorised in 6
groups (Table 2) or interpreted as positive or negative
based on a binary classification (25).
Table 1 Paediatric Mycobacterium tuberculosis contact
score incorporating measures of infectivity, proximity
and infectivity of documented exposure [29]
1 Is the index case the child’s mother?
2 Is the index case the child’s primary caretaker?
3 Does the index case sleep in the same bed as the child?
4 Does the index case sleep in the same room as the child?
5 Does the index case live in the same household as the child?
6 Does the index case see the child every day?
7 Is the index case coughing?
8 Does the index case have reported pulmonary tuberculosis?
9 Does the index case have smear positive sputum?
10 Is there more than one index case in the child’s house hold?
Note: a score of zero is assigned in the absence of any documented M.tb
exposure.
Table 2 Distribution of Ascaris-specific IgE values by RAST
classification in children (n =271)
RAST
rating
IgE level (kU/L) Frequency Row
percentage
0 < 0.351 206 76.01
1 0.35 - 0.692 17 6.30
2 0.70 - 3.493 31 11.40
3 + 3.50 + 4, 5, 6, 7 17 6.27
All Ascaris-specific IgE positive8 65 24.00
1Absent or undetectable allergen specific IgE.
2Low level of allergen specific IgE.
3Moderate level of allergen specific IgE.
4High level of allergen specific IgE: 3.50 - 17.49.
5Very high level of allergen specific IgE: 17.50 - 49.99.
6Very high level of allergen specific IgE: 50.0 - 100.00.
7Extremely high level of allergen specific IgE: > 100.00.
8 Any RAST response > 0.34 kU/L.
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Data analysis
Data analysis was performed using STATA/SE version
12.0 (StataCorp LP, StataCorp, 4905 Lakeway Drive, Col-
lege Station, Texas 77845 USA). An alpha level of less
than or equal to 0.05 was regarded as statistically signifi-
cant. The main outcome of interest was M.tb infection,
measured by a positive TST (≥10 mm). The main expos-
ure of interest, Ascaris IgE, was categorised according to
RAST categories and dichotomized (positive if ≥0.35kU/
L). This measure, consistent with previous work (25)
was used as a measure of Ascaris infection or
sensitization.
We assessed the effect of predictors of M.tb infection
in univariate analysis, with the primary determinant
being Ascaris IgE status in 271 enrolled participants.
Child baseline characteristics were described overall, and
stratified according to Ascaris IgE status for baseline
characteristics. Continuous data were described using
mean and standard deviations and median and inter-
quartile ranges, dependent on data distribution. Categor-
ical variables were described using frequencies and
percentages.
We developed logistic regression models that included
Ascaris IgE status, age and the M.tb contact score. These
measures were significant during univariate analysis or
were clinically or epidemiologically relevant as covari-
ates. Additionally, the developed model was examined
for interactions between the explanatory and environ-
mental variables in order to establish if possible effect
modification is present. Results of the regression model
are presented as adjusted odds ratios (aORs) and corre-
sponding 95 percent confidence intervals (95% CIs).
We complied with the Helsinki Declaration and the
study was approved by the Health Research Ethics Com-
mittee of the Stellenbosch University (reference number
N05/07/129 and N08/08/207).
Results
Of 337 total child participants enrolled, 271 HIV-
negative children were included in the analysis (n = 66,
20% were HIV infected and excluded). The median age
was 4 years (range: 4 months to 15 years).
Few children (2%) were receiving IPT at the time of
enrolment despite the fact that 67% of children were
household contacts of a tuberculosis index case cur-
rently on therapy. Of children with a documented con-
tact (n = 181), 121 were below 5 years of age and were
referred for IPT. Previous IPT use was reported in 9%
and 3% had previously received tuberculosis treatment.
Housing and socio-economic indicators indicate the
poor living conditions prevalent in these communities:
almost 20% of participants did not have access to a
fridge or radio at home while almost 5% relied occasion-
ally on selling household assets. Only 68% of children
lived in a house with a flushing toilet and 83% had ac-
cess to piped water in the household. The majority of
children resided in formal brick housing (77%) [Table 3].
Ascaris IgE results are described in Table 2. A total of
65 (24%) children were Ascaris IgE positive. Of these,
37% were also TST positive. Most Ascaris IgE positive
participants were within RAST range 2 (moderate level
of allergen specific IgE) followed by ranges 1 (low level
of allergen specific IgE) and 3 (high level of allergen spe-
cific IgE) [Table 2]. Of the 8% of children in whom the
caregiver reported that the child had passed a worm in
the preceding 3 months, most (86%) had been
dewormed. Anthropometric measures were not asso-
ciated with either positive Ascaris or TST status.
Overall, 40% of children were TST positive at enrol-
ment. Children were more likely to have a positive TST
if they were older (OR 1.2, p < 0.001), had a higher M.tb
contact score (OR 1.2, p < 0.001), had received previous
TB treatment (OR 4.8, p = 0.06) or previous IPT (OR
3.2, p = 0.01). A visible BCG scar (OR 0.4, p = 0.01) was
associated with reduced odds of infection [Table 4].
There was no significant association between positive
Ascaris IgE and positive TST status (OR= 0.9, 95% CI
0.5– 1.6, p = 0.63).
Based on the univariate analysis, we included age, M.
tb contact score and binary Ascaris IgE status in a re-
gression model that demonstrated an increased risk for a
positive TST in older children (aOR 1.2, 95% CI 1.1 –
1.3) and those with a higher M.tb contact score (aOR
1.2, 95% CI 1.1 – 1.3). This model also showed an in-
verse association between TST and Ascaris IgE positivity
(aOR 0.6, 95% CI 0.1 – 1.1).
A second model including M.tb contact score, age, As-
caris IgE and an age interaction term showed that the ef-
fect of age was stronger among those children with a
positive Ascaris IgE status. Being Ascaris IgE positive
significantly reduced the odds of being TST positive
amongst younger children, while this effect weakened as
age increased (Table 5).
Discussion
We demonstrate a high prevalence of M.tb and Ascaris
lumbricoides infection in children from households with
and without documented tuberculosis exposure living in
poor urban South African communities. Our results sug-
gest an inverse relationship between Ascaris IgE and
TST positive status, which is consistent with our
hypothesis.
False-negative TST results might be due to technical
factors or a suppressed immune status while false-
positive tests may be attributed to BCG vaccination and
the effect of non-tuberculous mycobacteria [12]. In our
study, a positive TST was associated with increasing age
and an increasing M.tb contact score, which is
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biologically plausible and consistent with other data
[30,34]. The presence of a BCG vaccination scar [35-37]
and indicators of higher socio-economic household sta-
tus [38] protected against having a positive M.tb infec-
tion phenotype.
Our multivariable logistic regression adjusting for age,
degree of M.tb exposure and previous TB therapy, sup-
ports this hypothesis; children with a positive Ascaris
IgE appeared to be less likely to mount a positive TST
response, especially if they were younger.
In the absence of stool samples, as in this study, serum
Ascaris-induced specific IgE is widely used as proxy
for Ascaris infection. Ascaris IgE however cannot dif-
ferentiate previous infection from new infection and/
or previous sensitization, and therefore assumes Ascaris
infection and Th2 polarization without information
regarding the time of infection [39], similar to measures
of M.tb infection. Additionally potential cross-reactivity
due to Trichiuris trichiura infection cannot be excluded
[40]. Despite these limitations, Ascaris IgE responses re-
main a useful proxy for immunological and epidemio-
logical studies, and are a standard and widely used
indication of Ascaris exposure/infections.
Despite universal clinic access to deworming and
school- based deworming programs, the positive Ascaris
IgE levels of 24%, although lower than previously
reported from these communities [26], are high and
consistent with WHO definitions for a helminth en-
demic country [9]. Deworming may not be practised as
regularly as required (at least once a year), as indicated
Table 3 Characteristics of child participants (n = 271)
Participant characteristics All participants
(n = 271)
Ascaris IgE
negative (n = 206)
Ascaris IgE
positive (n = 65)
TST negative
(<10 mm, n= 64)
TST positive
(≥10 mm, n= 107)
Age (median, inter-quartile range(IQR)) 4.4 (1.9 – 8.3)* }} 3.5 (1.6 – 6.7) 6.6 (4.5 - 10.3) 3.5 (1.6 – 5.7) 6.1 (3.2 – 10.2)
M.tb contact score (median (IQR)) 4 (0 – 5)* }} 4 (1 – 6) 3 (0 – 5) 4 (0 – 5) 5 (1 – 7)
Male gender (%) 111 (41.0) 82 (39.8) 29 (44.6) 68 (41.5) 43 (40.2)
Ethnicity (%)
African 55 (20.3) 47 (22.8) 8 (12.3) 32 (19.5) 23(21.5)
Mixed ancestry 216 (79.7) 158 (76.7) 57 (87.7) 132 (80.5) 84 (78.5)
BCG history or scar present (%) 221 (81.6) }} 172 (83.5) 49 (75.4) 143 (87.2) 78 (74.3)
Previous TB treatment (%) 8 (3.0) }} 5 (2.4) 3 (4.6) 2 (1.2) 6 (5.6)
Current IPT (%) 4 (1.5) 3 (1.9) 0 2 (1.2) 2 (1.9)
TST positive (%) 107(39.5) 83 (40.3) 24(36.9) NA NA
History of passing a worm in <3 months (%) 21 (7.8) 13 (6.3) 7 (87.5) 15 (9.2) 6 (5.6)
History of deworming in < 3 months3 (%) 18 (6.6) 11 (5.3) 8 (12.3) 13 (7.9) 5 (4.7)
Anthropometric data (mean (SD))
Weight for age −0.55 (1.20) −0.49 (1.2) −0.76 (1.3) −0.48 (1.3) −0.67 (1.1)
Height for age −1.29 (1.6) −1.27 (1.6) −1.34 (1.5) −1.20 (1.9) −1.42 (0.9)
Weight for height 0.35 (1.2) 0.40 (1.2) 0.13 (1.1) 0.41 (1.2) 0.22 (1.1)
Socio-economic indicators and household demographics
Presence of a radio in household (%) 217 (80.1) }} 163 (79.) 54 (83.1) 139 (84.8) 78 (72.9)
Presence of a refrigerator in household (%) 221 (81.6) }} 166 (80.6) 55 (84.6) 144 (87.8) 77 (72.0)
Relying on the sale of household assets (%) 13 (4.8) 12 (5.8) 1 (1.5) 8 (4.9) 5 (4.7)
Flush toilet in the house (%) 184 (67.9) 141 (68.5) 43 (66.2) 114 (69.5) 70 (65.4)
Piped running water in residence (%) 225 (83.0) 169 (82.0) 56 (86.2) 137 (83.5) 88 (82.2)
Housing structure (%)
Tin shack 36 (13.4) 30 (14.6) 6 (9.5) 19 (1.7) 17 (16.1)
Brick 205 (76.5) 154 (75.1) 51 (81.0) 128 (78.5) 77 (73.3)
Other 27 (10.1) 21 (10.2) 6 (9.5) 16 (9.8) 11 (10.5)
Household composition (median (IQR))
Number of adults 5 (3 – 6) 5 (3 – 6) 4 (3 – 7) 5 (3 – 6) 4 (2 – 6)
Number of children 3 (2 – 5) 3 (2 – 5) 4 (2 – 5) 4 (2 – 5) 3 (2 – 4)
Median ratio of adult:children 1.25 (1 – 1.8) 1.25 (1 – 1.8) 1.25 (1–1.8) 1.25 (1 – 1.9) 1.25 (1 – 1.8)
TB = tuberculosis; BCG=bacillus Calmette-Guérin; IPT = Isoniazid preventive therapy, TST = tuberculin skin test.
*Ascaris groups significantly different, P-value ≤0.05.
}} TST groups significantly different, P-value ≤0.05.
van Soelen et al. BMC Infectious Diseases 2012, 12:211 Page 5 of 8
http://www.biomedcentral.com/1471-2334/12/211
by the low proportion of caregivers (7%) who had
reported deworming of the child in the preceding
3 months. On the other hand, helminth re-exposure and
infection, given the poor socio-economic circumstances
is also possible [9,38]. These factors should be investi-
gated in longitudinal studies with repeat measures of
infection.
Older children (OR 1.2, p < 0.001) were more likely to
be Ascaris positive which we attribute to the age-related
risk of infection and immune system responsiveness,
and possibly due to behavioural patterns (i.e. more out-
door activities in shared environments like schools and
sports fields).
Few children were on IPT at enrolment which could
reflect the active contact tracing strategy used by the
study; however previous studies from these communities
indicate poor IPT uptake and adherence in young chil-
dren under routine programmatic conditions [41-43].
This study is limited by its cross-sectional nature, the
limited sample size and the exclusion of HIV-infected
children, due to small numbers. The enrolment strategy
was purposeful to ensure a high proportion of children
with recent M.tb exposure and included children from
neighbouring “control” households as a measure of
background M.tb transmission. Finally, the proxy used
for Ascaris in our study does not apply to all potential
helminth species, and might underestimate the general
and differential effect of helminth infection. Deworming
was only reported on a questionnaire basis and its im-
pact on mycobacterial and other immune responses
could therefore not be rigorously evaluated.
In light of these limitations, these results need to be
verified in paediatric cohort studies, preferably with add-
itional measures of helminth infection including stool
samples and the standard evaluation of the effect of
deworming on mycobacterial immune responses.
Conclusions
The results support our hypothesis that helminth infec-
tion may change immune responses in children. This
may play a clinically measureable role in widely used im-
mune diagnostic tests that measures M.tb infection, es-
pecially in high prevalence tuberculosis and helminth
infection settings.
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Table 5 Multivariable logistic regression model of
predictors of TST positivity in children
Model 1:
aOR (95% CI)
Age 1.22 (1.13 – 1.32), p < 0.001
TB contact score 1.21 (1.09 – 1.34), p < 0.001
Ascaris IgE positive 0.55 (0.28 – 1.07), p = 0.08
Model 2: Interaction between Helminth Positive/Negative and Age
TB contact Score 1.22 (1.10 - 1.34)
Age effect
IgE negative 1.17 (1.08 - 1.27)
IgE positive 1.44 (1.21 - 1.73)
IgE effect
25% age 0.18 (0.05 - 0.67)
50% age 0.30 (0.11 - 0.78)
75% age 0.67 (0.32 - 1.39)
aOR = adjusted Odds ratio, 95% CI = 95 percent confidence interval.
Table 4 Univariate analysis of predictors for Ascaris-
specific IgE positivity (n =271)
Ascaris IgE positive (n = 65)
OR 95% CI p-value
Age 1 1.20 1.11 – 1.29 <0.001
TB contact score1 0.88 0.80 – 0.98 0.02
Male gender 1.22 0.69 – 1.14 0.49
Ethnicity African 0.47 0.21 – 1.06 0.07
Mixed ancestry 2.12 0.94 – 4.76 0.07
BCG history or scar present 0.63 0.32 – 1.25 0.18
Previous TB treatment 1.95 0.45 – 8.37 0.37
History of recent worm 2.08 0.82 – 5.28 0.12
History of recent deworming
(< 3 months)
1.27 0.10 – 16.81 0.86
Z-scores Weight for age 0.81 0.63 – 1.05 0.11
Height for age 0.97 0.80 – 1.17 0.76
Weight for height 0.81 0.60 – 1.10 0.18
Socio-economic indicators and household demographics
Presence of a radio in the household 1.30 0.62 – 2.69 0.49
Presence of a refrigerator in the
household
1.33 0.62 – 2.83 0.47
Relying on the sale of household
assets
0.25 0.03 – 1.98 0.19
Access to flush toilet facility in the
house
0.90 0.50 – 1.63 0.73
Piped running water in the house 1.36 0.62 – 3.00 0.44
Living in a brick house 1.23 0.63 – 2.40 0.54
Household composition
Number of adults in household 0.01 0.90 – 1.14 0.83
Number of children in household 1.08 0.94 – 1.25 0.28
Median ratio of adults:children 0.98 0.74 – 1.31 0.91
BCG, bacillus Calmette-Guérin; TB, tuberculosis.
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